Literature DB >> 2666632

Invasive aspergillosis: clinical and pathological features of a new animal model.

C L Spreadbury1, T Krausz, S Pervez, J Cohen.   

Abstract

A new animal model of invasive aspergillosis is described in which female New Zealand White rabbits were immunosuppressed with corticosteroids and cyclophosphamide and were given an intratracheal inoculation of 4 x 10(4) conidia of Aspergillus fumigatus. Thirteen of 15 animals survived during a 10-day-period of observation. Most had clinical signs of a respiratory infection (dyspnoea) and at autopsy there was macroscopic and microscopic evidence of invasive pulmonary aspergillosis. Six control animals (infected but not immunosuppressed) showed no such signs. The extent of hyphal invasion was assessed histologically and quantified by calculating the number of colony forming units (c.f.u.) g-1 of tissue: in the experimental group the mean c.f.u. value for the lungs was 1.25 x 10(3) compared to 73.3 c.f.u. g-1 of lung for the control group (P = 0.003). The infection was also quantified by a whole lung chitin assay: in the experimental group the mean chitin content (expressed as a glucosamine equivalent) was 3.05 micrograms g-1 lung tissue compared to a 0.53 micrograms g-1 lung tissue for the control group (P = 0.01). We conclude that this model of invasive aspergillosis in rabbits reflects closely the pathological features of the disease in man and that it may prove useful for studies of the pathogenesis and the treatment of invasive aspergillosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666632     DOI: 10.1080/02681218980000021

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  11 in total

1.  Efficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary Aspergillosis in neutropenic mice.

Authors:  Ryogo Hayashi; Naomi Kitamoto; Yuji Iizawa; Takashi Ichikawa; Katsumi Itoh; Tomoyuki Kitazaki; Kenji Okonogi
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 2.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  Study on the hyphal responses of Aspergillus fumigatus to the antifungal agent by Bio-Cell Tracer.

Authors:  L Ansheng; H Taguchi; M Miyaji; K Nishimura; S Wu
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

4.  Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.

Authors:  Russell E Lewis; Randall A Prince; Jingduan Chi; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

5.  Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis.

Authors:  J M Smith; C M Tang; S Van Noorden; D W Holden
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis.

Authors:  C M Tang; J Cohen; T Krausz; S Van Noorden; D W Holden
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Invasive aspergillosis in two patients with acute lymphoblastic leukaemia in complete remission.

Authors:  M L Turner; L Russell; L J Milne; A C Parker
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

8.  The effect of elastase-specific monoclonal and polyclonal antibodies on the virulence of Aspergillus fumigatus in immunocompromised mice.

Authors:  M B Frosco; T Chase; J D Macmillan
Journal:  Mycopathologia       Date:  1994-02       Impact factor: 2.574

9.  Bronchoalveolar lavage in an immunosuppressed rabbit model of invasive pulmonary aspergillosis.

Authors:  E R Chilvers; C L Spreadbury; J Cohen
Journal:  Mycopathologia       Date:  1989-12       Impact factor: 2.574

10.  Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection.

Authors:  R Nawada; R Amitani; E Tanaka; A Niimi; K Suzuki; T Murayama; F Kuze
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.